Neoadjuvant immunotherapy in early-stage NSCLC: navigating biomarker dilemmas and special population challenges. Chen T, Liu F. Lung Cancer 2025;204:108588.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen T, Liu F. Neoadjuvant immunotherapy in early-stage NSCLC: navigating biomarker dilemmas and special population challenges. Lung Cancer 2025;204:108588.
PMID: 40409027